Table 3 FASN staining in atypical and cancerous breast
From: Characterization of a novel anti-fatty acid synthase (FASN) antiserum in breast tissue
Diagnosis | Number of cases staining (percentage) |
|---|---|
Columnar cell lesions (non-atypical) | 85/116 (73%) |
Flat epithelial atypia | 26/33 (79%) |
Apocrine carcinoma | 2/2 (100%) |
Invasive breast cancer (all types) | 383/743 (52%) |
